Pay in 4 interest-free payments of $27.50 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy
It also decreases expression of HIF-1α and VEGF in breast cancer and glioma cells
45(12):3544-7
Pro-apoptotic effect of ZT-12-037-01 is dramatically enhanced in cells expressing oncogenic NRAS
GSK2190915 Sodium Salt - CAS# 1196070-26-4 Size:Solid 2 mg Phase II study of olaparibFiboflapon Sodium is a 5 lipoxygenase inhibitor potentially for the treatment of asthma. Product information CAS Number: 1196070 26 4 Molecular Weight: 659. 81 Formula: C38H42N3NaO4S Synonym: GSK 2190915A Fiboflapon sodium AM 803 sodium Chemical Name: sodium 3 [3 (tert butylsulfanyl) 1 {[4 (6 ethoxypyridin 3 yl)phenyl]methyl} 5 [(5 methylpyridin 2 yl)methoxy] 1H indol 2 yl] 2,2 dimethylpropanoate Smiles: [Na+].
US$ 285.00
US$ 44.00
US$ 170.00
US$ 282.50
US$ 747.50